Stem cell research.
Some people consider the brain to be equivalent to a living computer and in that sense it’s too bad that computers don’t have the equal of neural stem cells to help them fix themselves. Is the internet one big neural network-like web? There was a quake in the stem cell internet as CIRM’s main website […]
Weekly reads: neural stem cells, CRISPR brain, Vertex, cytoplasm surprise Read More »
I remember the first time I ever witnessed human cell division first hand and it was really excitement. I was working as a part-time tech in the Lane Lab at UC San Diego School of Medicine. We studied heart disease and grew human umbilical cord endothelial cell cultures. It was striking to see a plate
Weekly reads: Vertex hold, new type of cell division in fish, CAR-T Read More »
This has been one of those weeks where I spent some time thinking about taking risks in science. How much risk one should take? Risks can come in many forms. It could be at the core level at the bench doing specific experiments and not others. There’s risk in clinical trials, and even in advocacy. Sometimes
Weekly science reads: Macchiarini trial, somites, CRISPR babies Read More »
Today’s post lists the best stem cell blogs and more generally the top biology blogs as well as websites. Making lists of “the best” of anything is fun yet it can be tricky. However, I feel that it can also serve a purpose as a resource. You might also enjoy these other “top” lists I’ve
22 best biology & stem cell blogs for 2022 Read More »
It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which
Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »
In trying to figure out how unproven stem cell clinics get so many customers, I’ve found that these firms can in part thank Google. I recently wrote a guest piece on STAT News about this problem and called on Google to fix it. However, just this week I stumbled on another case of Google search
Google gets it dangerously wrong on stem cell side effects Read More »
Sometimes a post here on The Niche (named after the stem cell niche) sparks a debate between expert stem cell researchers and often that gives much more depth to a topic. Such was the case with my post this week on where things stand with stem cell therapy for heart disease. It led to a
Weekly reads: Melton leaves Harvard, Fuji, BBC blunder, stem cell niche, more Read More »
How much promise is there today for stem cell therapy for heart disease? Where do things stand with the clinical research? Patients regularly ask me these kinds of questions. The goal of today’s post is to update you on where things stand. What’s in this post Stem Cell Therapy | Clinical Trials | Delivery of
Stem cell therapy for heart disease: what you need to know Read More »
David Weinberg over at Science-Based Medicine has his part two of a deep dive into the so-called SCOTS trial, which is a non-traditional pay-for-play study. I highly recommend it. SCOTS trial under the magnifying glass In this piece, Weinberg provides interesting background on the two people running SCOTS. I’ve had many concerns about the SCOTS
Recommended reads: engineered niche, ALS, SCOTS trial, human genome “done” Read More »
Science must go on and so must stem cell meetings in 2022 with all those great conferences out there, but hopefully this year will be better than 2020-2021. It seems that way with the pandemic easing in the U.S. and many other places. On the other hand, COVID is spiking in Asia and other regions.
Hub of Regenerative Medicine & Stem Cell Meetings 2022 Read More »